GHK-Cu Mechanism of Action — Research Reference
Copper-coordination chemistry, gene-expression modulation, SOD/antioxidant activity, and matrix remodelling pathways defining GHK-Cu in tissue-repair research.
GHK-Cu Mechanism of Action — Research Reference
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. The copper coordination is integral — most of GHK-Cu's published activity depends on the chelated metal, not the free tripeptide.
Copper Coordination
The peptide forms a square-planar Cu(II) complex through the N-terminal amine, the imidazole nitrogen of histidine, and the deprotonated amide nitrogen of the glycyl-histidyl bond. The result is a stable carrier that buffers and delivers copper to receiving tissues without the redox toxicity of free Cu²⁺.
Mechanism Pillars
- Gene-expression modulation — published transcriptomic work documents GHK-Cu influence on hundreds of human genes, including upregulation of antioxidant defence (SOD1, SOD2), matrix-remodelling enzymes (MMPs, TIMPs), and collagen synthesis genes; downregulation of inflammatory and senescence-associated transcripts.
- Antioxidant activity — the copper centre catalytically dismutates superoxide and supports SOD-like activity; combined with upregulation of intrinsic SOD this produces a layered antioxidant effect in dermal models.
- Matrix remodelling — GHK-Cu stimulates fibroblast collagen, elastin, and glycosaminoglycan synthesis while regulating the protease/inhibitor balance that governs scar architecture.
- Angiogenesis — published wound models show enhanced capillary formation associated with VEGF and FGF upregulation in the wound bed.
- Hair-follicle signalling — published follicle-organ-culture studies report enlargement of the dermal papilla and prolonged anagen phase.
Pharmacokinetics
GHK-Cu is rapidly cleared from plasma when administered parenterally but produces durable gene-expression changes that persist beyond plasma half-life. Topical penetration depends on formulation; copper delivery to the dermis is the rate-limiting step in cosmetic-research models.
Loss-of-Function Verification
In comparison studies, free GHK (peptide stripped of copper) shows substantially attenuated activity across most published endpoints — confirming the copper ion is central to the mechanism rather than incidental.
Research Use Only. All content is for laboratory research and educational reference. Compounds discussed are not intended for human or veterinary consumption.
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018;19(7):1987.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
- Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343–346.
Related Research Materials
Parent Research Hubs
Related Research Articles
Semaglutide Mechanism of Action — Receptor, Signalling & Pharmacokinetics
Receptor pharmacology of the long-acting GLP-1 receptor agonist semaglutide: binding affinity, downstream Gαs/cAMP/PKA signalling, gastric emptying, central appetite circuits and albumin-anchored PK.
Tirzepatide Mechanism of Action — Dual GIP/GLP-1 Receptor Pharmacology
Receptor pharmacology of the dual GIP/GLP-1 receptor agonist tirzepatide: imbalanced agonism, downstream signalling differences from semaglutide, and the metabolic consequences of GIP arm activation.
BPC-157 Mechanism of Action — Angiogenesis, NO Pathway & Growth Factor Crosstalk
Proposed mechanisms of stable gastric pentadecapeptide BPC-157: VEGFR2 phosphorylation, nitric oxide pathway modulation, growth-factor crosstalk and gastrointestinal cytoprotection.